Image Ben Hargreaves Market Access FDA’s treatment of China-developed drugs spurs demands for m... China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline. Digital Sleep tracking and the potential for digital endpoints Sleep and its importance to health is becoming a greater focus of research. Market Access Orphan drugs' financial success raises questions R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. Digital Could virtual reality become an essential tool for healthcar... The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. Load more results
Market Access FDA’s treatment of China-developed drugs spurs demands for m... China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline.
Digital Sleep tracking and the potential for digital endpoints Sleep and its importance to health is becoming a greater focus of research.
Market Access Orphan drugs' financial success raises questions R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any.
Digital Could virtual reality become an essential tool for healthcar... The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
